Access cutting-edge peripheral arterial disease (pad) treatment through this clinical trial at a research site in Salem. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Salem location
Preparing your pre-screening questions…
Access peripheral arterial disease (pad) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related peripheral arterial disease (pad) treatment provided free
Check if you qualify for this peripheral arterial disease (pad) clinical trial in Salem, MA
No-Cost Study Care
Local to Salem
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery disease (PAD) who have undergone a procedure to restore blood flow to their legs. The main questions it aims to answer are: * Does the personalized plan lower the rate of blood clots in the treated leg one year after the procedure? * Does the personalized plan lower rates of amputation, repeat procedures, bleeding, and death compared to standard treatment? Researchers will compare the personalized TARGET plan which uses a blood test to tailor each person's blood clot prevention medication to the standard treatment to see if the personalized approach works better. Participants will: * Be randomly assigned to either the personalized TARGET plan or standard treatment after their procedure * Have blood tests at 1 week and at 1, 3, 6, 9, and 12 months after their procedure * Have medications adjusted based on blood test results if assigned to the TARGET group
Sponsor: Massachusetts General Hospital
Yes, this clinical trial (NCT07613840) has an active research site in Salem, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for peripheral arterial disease (pad) treatment options in Salem, MA, this clinical trial (NCT07613840) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Salem research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral arterial disease (pad) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all peripheral arterial disease (pad) clinical trials near you to find additional studies recruiting in your area.
See all peripheral artery disease clinical trials recruiting in Salem — not just this study.
Browse Peripheral Artery Disease Trials in Salem →